A Multi-center, Double-blind, Parallel-group, Placebo Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 70 Years Old) With Partial Onset Seizures.

Trial Profile

A Multi-center, Double-blind, Parallel-group, Placebo Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 70 Years Old) With Partial Onset Seizures.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2017

At a glance

  • Drugs Brivaracetam (Primary)
  • Indications Partial epilepsies
  • Focus Registrational; Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 18 Dec 2016 Results of pooled analysis of three phase III studies including this study published in the Epilepsia
    • 22 Jun 2016 Results (pooled analysis of this and other two studies) assessing efficacy, safety, and tolerability of adjunctive brivaracetam published in the Neurology.
    • 21 Apr 2016 Pooled analysis (N=1160) assessing efficacy of brivaracetam as adjunctive therapy in partial onset seizures of 3 studies (NCT00490035, NCT00464269, NCT01261325) were presented at the 68th Annual Meeting of the American Academy of Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top